What is EN Rx?
EN Rx LLC is a specialized provider of advanced environmental solutions designed to tackle complex ecological challenges and enhance property valuations. The company's core offerings include the Vertebrae Well System for efficient remediation and assessment in difficult-to-access locations, and the highly stable and potent EN Rx Reagent for oxidation processes. Serving environmental consultants, regulatory bodies, and various stakeholders in remediation projects, EN Rx is dedicated to transforming environmental work practices for improved safety and efficacy.
How much funding has EN Rx raised?
EN Rx has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in EN Rx
PPP
Public-Private Partnership
What's next for EN Rx?
The substantial late-stage funding indicates EN Rx is poised for significant scaling and market expansion. This capital injection is likely to fuel further research and development of their proprietary environmental technologies, potentially leading to new product lines or enhanced capabilities for their existing systems. Strategic partnerships and broader market penetration are anticipated as the company leverages this investment to solidify its leadership in the environmental remediation sector.
See full EN Rx company page
